{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:59:30Z","timestamp":1790629170045,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>To describe the presentation of both new-onset and reactivation of thyroid eye disease (TED) following COVID-19 vaccination. Single-institution retrospective case series of patients presenting with symptoms and signs of new or reactivated TED coinciding with recent COVID-19 vaccination. Data collected included patient age, gender, presenting symptoms, ocular history, clinical signs, and interval duration between vaccination and onset of ocular symptoms. Three female patients were identified. All patients were over 18 years of age (range 45\u201366 years). Patients received either the Moderna or Pfizer COVID-19 vaccine and presented with symptoms of TED within 24 h to 21 days of receiving their first or second dose. None of the patients had previous infections with severe acute respiratory syndrome coronavirus 2. Two patients had a history of inactive TED with stable thyroid function tests: One of these patients had stable disease for at least 15 years and the other had stable disease for 5 years. The third patient had no previous history of thyroid dysfunction or TED and presented with low levels of thyroid-stimulating hormone. All three cases presented with proptosis. In two of three cases, periorbital edema, eyelid retraction, and diplopia were present. None were current smokers. One had prior facial hyaluronic acid filler injections. Symptoms in all cases were improving at 4 to 8 months. While the possibility of unrelated TED flaring concurrently with COVID-19 vaccination exists, questions remain on the effects of the COVID-19 vaccine in patients with autoimmune ophthalmic diseases. Physicians should be aware of this potential association and counsel patients appropriately.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo_61_21","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T04:55:38Z","timestamp":1645851338000},"page":"93-96","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Thyroid eye disease reactivation associated with COVID-19 vaccination"],"prefix":"10.4103","volume":"12","author":[{"given":"Kathryn S.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammie E.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Ozzello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sook","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby S.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don O.","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20240830","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R2-15-20240830","first-page":"477","article-title":"The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota","volume":"92","author":"Bartley","year":"1994","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R3-15-20240830","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.41734","article-title":"American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: Version 1","volume":"73","author":"Curtis","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R4-15-20240830","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2665-9913(21)00108-9","article-title":"Flare of rheumatoid arthritis after COVID-19 vaccination","volume":"3","author":"Terracina","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"R5-15-20240830","doi-asserted-by":"crossref","first-page":"107970","DOI":"10.1016\/j.intimp.2021.107970","article-title":"Autoimmune phenomena following SARS-CoV-2 vaccination","volume":"99","author":"Ishay","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R6-15-20240830","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines (Basel"},{"key":"R7-15-20240830","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ene.15147","article-title":"Neurological autoimmune diseases following vaccinations against SARS-CoV-2: A case series","volume":"29","author":"Kaulen","year":"2022","journal-title":"Eur J Neurol"},{"key":"R8-15-20240830","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/thy.2021.0142","article-title":"Two cases of Graves\u2019 disease following SARS-CoV-2 vaccination: An autoimmune\/inflammatory syndrome induced by adjuvants","volume":"31","author":"Vera-Lastra","year":"2021","journal-title":"Thyroid"},{"key":"R9-15-20240830","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/clinem\/dgab373","article-title":"Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: Postvaccination ASIA syndrome","volume":"106","author":"\u0130remli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-15-20240830","doi-asserted-by":"crossref","first-page":"103211","DOI":"10.1016\/j.amjoto.2021.103211","article-title":"SARS-CoV-2 vaccine-induced subacute thyroiditis","volume":"43","author":"Patel","year":"2021","journal-title":"Am J Otolaryngol"},{"key":"R11-15-20240830","doi-asserted-by":"crossref","first-page":"e04812","DOI":"10.1002\/ccr3.4812","article-title":"Subacute thyroiditis following COVID-19 vaccination","volume":"9","author":"Soltanpoor","year":"2021","journal-title":"Clin Case Rep"},{"key":"R12-15-20240830","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/IOP.0000000000002059","article-title":"Thyroid eye disease following COVID-19 vaccine in a patient with a history graves\u2019 disease: A case report","volume":"37","author":"Rubinstein","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R13-15-20240830","doi-asserted-by":"crossref","first-page":"374","DOI":"10.36849\/JDD.6041","article-title":"Global recommendations on COVID-19 vaccines and soft tissue filler reactions: A survey-based investigation in cooperation with the International Society for Dermatologic and Aesthetic Surgery (ISDS)","volume":"20","author":"Gotkin","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"R14-15-20240830","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/jocd.14312","article-title":"Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination \u2013 A case report","volume":"20","author":"Michon","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R15-15-20240830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2019ASIA\u2019 \u2013 Autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.tjo_61_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:46Z","timestamp":1787166706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.tjo_61_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo_61_21","relation":{},"ISSN":["2211-5056"],"issn-type":[{"value":"2211-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}